NM_144585.4:c.269G>A
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 10P and 1B. PM2PP5_Very_StrongBP4
The NM_144585.4(SLC22A12):c.269G>A(p.Arg90His) variant causes a missense change. The variant allele was found at a frequency of 0.000103 in 1,612,014 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_144585.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152178Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000178 AC: 44AN: 246684Hom.: 0 AF XY: 0.000224 AC XY: 30AN XY: 134192
GnomAD4 exome AF: 0.000105 AC: 153AN: 1459718Hom.: 1 Cov.: 35 AF XY: 0.000107 AC XY: 78AN XY: 726262
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152296Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74468
ClinVar
Submissions by phenotype
Dalmatian hypouricemia Pathogenic:6
- -
The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.018%). Missense changes are a common disease-causing mechanism. Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000003516). The variant has been reported to be in trans with a pathogenic variant as either compound heterozygous or homozygous in at least 2 similarly affected unrelated individuals (PMID: 15741204, 16703794, 22045201). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. -
- -
- -
Across several studies, the SLC22A12 c.269G>A (p.Arg90His) missense variant has been reported in at least 18 individuals with renal hypouricemia including two homozygotes, 15 compound heterozygotes, and one heterozygote, who present with phenotypes ranging from no clinical symptoms to acute kidney injury after strenuous exercise (Ichida et al. 2004; Iwai et al. 2004; Ishikawa et al. 2005; Cheong et al. 2005; Komatsuda et al. 2006; Inazu et al. 2007; Ichida et al. 2008; Lee et al. 2008; Ochi et al. 2012). Ishikawa et al. (2005) noted that the p.Arg90His variant segregated with disease in multiple members of a large family. The variant was absent from 192 controls, but is reported at a frequency of 0.00237 in the East Asian population of the Exome Aggregation Consortium. Ichida et al. (2004) demonstrated that urate transport activity for the p.Arg90His variant in Xenopus oocytes was significantly decreased in comparison with that of wild type and was similar to that of oocytes that were not injected with URAT1 cRNA. Ichida et al. (2004) also demonstrated through immunocytochemical analysis that the variant exhibited similar staining patterns to wild type in the plasma membrane of Xenopus oocytes. Based on the collective evidence, the p.Arg90His variant is classified as pathogenic for renal hypouricemia. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. -
- -
not provided Pathogenic:1
This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 90 of the SLC22A12 protein (p.Arg90His). This variant is present in population databases (rs121907896, gnomAD 0.2%). This missense change has been observed in individual(s) with renal hypouricemia (PMID: 15741204, 16703794, 18492088, 30097038). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 3516). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects SLC22A12 function (PMID: 33821957). For these reasons, this variant has been classified as Pathogenic. -
Familial renal hypouricemia Pathogenic:1
The p.Arg90His variant in SLC22A12 has been identified in the homozygous or comp ound heterozygous state in at least 10 individuals with hypouricemia, most of wh om had Asian ancestry, (Iwai 2004, Ichida 2004, Komatsuda 2006, Inazu 2007, Lee 2008, Tasic 2011) and segregated with disease in 2 affected members from 1 famil y (Ishikawa 2005). All of these individuals had biochemical features consistent with hypouricemia, but only a subset were clinically affected. In vitro function al studies support an impact to protein function (Ichida 2004). This variant has been identified in 0.2% (37/17126) of East Asian chromosomes by gnomAD (http:// gnomad.broadinstitute.org). This frequency is consistent with the reported reduc ed penetrance for this disorder. In summary, this variant meets criteria to be c lassified as pathogenic for autosomal recessive hereditary renal hypouricemia, w hich has significantly reduced clinical penetrance, based on case observations a nd segregation studies. ACMG/AMP Criteria applied: PM3_VeryStrong, PP1_Moderate. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at